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Anti-NMDA-R Encephalitis—an Encephalitis Lethargica-like Illness
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A girl of 3 years and 9 months with a 3-day history of fever and upper respiratory tract infection (URTI) 
was admitted with a generalised tonic-clonic convulsion, and delirium with screaming, non-sense 
talking, and agitation. For the first week after admission, she was lethargic with fluctuating awareness 
and mutism during the day but poor sleep at night. Workup for acute encephalopathy including 
autoimmune, infective, toxicology, metabolic and vasculitic screening showed negative findings. 
Erythrocyte sedimentation rate was markedly elevated and cerebrospinal fluid showed positive 
oligoclonal bands. Urgent MRI brain showed bilateral periventricular, multifocal hyperintense lesions 
on T2W and FLAIR images over the frontal, parietal and occipital regions without enhancement. Urgent 
electroencephalogram showed generalised slowing compatible with encephalopathic picture. Acute 
demyelinating encephalomyelopathy was initially suspected, and she was first given intravenous (IV) 
methylprednisolone, 30 mg/kg/day, for 5 days without evident response, and then IV immunoglobulin, 
1 g/kg, for 2 days. After this treatment, there was some improvement in conscious level but the child 
remained mute. Repeated electroencephalogram showed improved slowing and sleep changes. In the 
second week, she developed dyskinesia with mouth chewing, tongue thrushing and finger rolling, and 
developed rigidity, dystonia and oculogyric crises. The dystonia caused mild rhadomyolysis with raised 
creatine kinase level. Encephalitis lethargica was suspected and L-dopa was started. After dose titration, 
she responded well to L-dopa at 1.5 mg/kg qid with improvement of dystonia and rigidity. At the third 
week, however, she developed recurrent generalised tonic-clonic convulsions. Phenytoin and sodium 
valproate were started. Repeated MRI brain confirmed increase hyperintensity and size of the previously 
demonstrated lesions (T2W and FLAIR images) with additional pons involvement, and evidence of 
cerebral atrophy. In view of both clinical and radiological evidences of active ongoing encephalitic 
process, a second course of IV immunoglobulin followed by methylprednisolone was given. After the 
second course of treatment, the child responded well with ongoing improvement. She regained full 
consciousness and remained seizure-free. After half a month of rehabilitation training, she could walk on 
her own recommenced full oral feeding. She remained mute, but had normal understanding for her age. 
Her speech gradually returned 2 months after onset of illness. As this girl has encephalitis lethargica-like 
illness, NMDA-R encephalitis was suspected. NMDA-R antibodies in both serum and cerebrospinal fluid 
confirmed raised titres. Ultrasonogram of pelvis was normal. 
 In summary, this 3-year-old girl who developed a post-URTI encephalopathy with neuropsychiatric 
presentation, movement disorder, mutism, sleep disorder and seizures, symmetrical white matter 
changes, improvement after IV immunoglobulins and steroids, has anti-NMDA-R encephalitis. Her clinical 
features were typical of anti-NMDA-receptor encephalitis1 which is associated with antibodies against 
the NR1-NR2 heteromers of the NMDA receptor, and often ovarian tumours in young adult females. The 
same antibodies have been shown in children with ‘encephalitis lethargica’.2 Long-term follow-up and 
monitoring of antibody titres are important as relapse may occur in some of the affected patients. This is 
the first case of anti-NMDA receptor encephalitis reported in Hong Kong. 
References
1.	 Dalmau	 J,	Gleichman	AJ,	Hughes	EG,	et	al.	Anti-NMDA-receptor	encephalitis:	case	 series	and	analysis	of	 the	effects	of	
antibodies.	Lancet	Neurol	2008;7:1091-8.
2.	 Dale	RC,	Irani	SR,	Brilot	F,	et	al.	N-methyl-D-aspartate	receptor	antibodies	in	pediatric	dyskinetic	encephalitis	lethargica.		Ann	
Neurol.	Epub	2009	July	20.
P 14
